Evidence map›Paper›PMID 33584864›Full record

ReviewDer nephrologe2021

[Rehabilitation after kidney transplantation].

Doris Gerbig

Open access · hybridAbstract readEnglish AbstractReview
In one paragraph

Review in Der nephrologe, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Doris GerbigFachklinik Bad Heilbrunn, Innere Medizin - Nephrologie/Transplantationsnachsorge, m&i - Fachklinik Bad Heilbrunn, Wörnerweg 30, 83670 Bad Heilbrunn, Deutschland.
Diabetes-Akademie · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStructured follow-up care starting immediately after the transplantation and living donation and ideally continuing long-term, can improve transplant survival and aid in the detection of risk factors for physical and psychological morbidity of various origins. In addition to classical cardiovascular risk factors, these include a lack of patient adherence, knowledge deficits with respect to the rules of conduct after transplantation and living donation, lack of exercise and coping strategies and also occupational health and social law issues.

objectiveThis article aims to clarify how rehabilitation measures can optimize the aftercare following kidney transplantation and living donation, what the need for rehabilitation is based on, what goals are pursued and which multidisciplinary therapy modules have been established. MATERIAL AND

methodsFor this purpose, the experiences of a rehabilitation clinic offering rehabilitation after kidney transplantation and living donation and currently treats approximately 600 patients per year since 2000, have been considered in addition to a literature search.

resultsGiven the complexity surrounding posttransplantation aftercare, specialized rehabilitation measures focusing on nephrology and transplantation medicine can meaningfully supplement outpatient aftercare after kidney transplantation and living donation, if the rehabilitation clinic fulfils conceptual, personnel, and structural quality requirements. A close cooperation between the rehabilitation clinic, the transplantation center, and the treating nephrologist is essential.

conclusionControlled studies on the effects of long-term aftercare including inpatient rehabilitation are still needed. In this context, prerehabilitation should also be included.

Indexed as

AftercareKidneysLiving donationRehabilitationTransplant survival

Identifiers

PMID33584864
PMCPMC7869762
OpenAlexW3131054341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.